Clinical trial
Non-invasive Disease Activity Monitoring in Patients With Inflammatory Bowel Disease (IBD) Using Volatile Organic Compounds
NCT04827368 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Non-invasive Disease Activity Monitoring in Patients With Inflammatory Bowel Disease (IBD) Using Volatile Organic Compounds
- Lead sponsor
- The Cleveland Clinic
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 22, 2021
- Completion date
- June 30, 2026
- Enrollment
- 292 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
crohn disease, ibd, ulcerative colitis